Placebo News and Research

RSS

Research: Pure omega-3 prescription drug significantly reduces the occurrence of ischemic events

Taking a high dose of icosapent ethyl--a pure and stable prescription form of the omega-3 fatty acid known as EPA--significantly reduces the occurrence of first, subsequent and total ischemic events, including heart attacks, strokes and related deaths, among people at high cardiovascular risk despite already being on statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

19 Mar 2019

Study indicates the benefits of stopping aspirin in heart attack patients

Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12inhibitor—clopidogrel, prasugrel or ticagrelor—did not experience higher rates of death from any cause, heart attack or stroke after a year compared with those receiving standard therapy, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke

Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or "bad" cholesterol, after 12 weeks compared to similar patients who took a placebo in addition to statin therapy, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

One-off surgery could offer hope to patients with high blood pressure

A one-off operation that targets the nerves connected to the kidney has been found to maintain reduced blood pressure in hypertension patients for at least six months, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust, and supported by the National Institute for Health Research.

18 Mar 2019

Cardiovascular benefits of diabetes drug extend across a wide spectrum of patients, shows study

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

18 Mar 2019

Researchers report promising results of potential reversal agent

In patients with acute coronary syndromes, coronary artery stenting, or a history of prior heart attacks, antiplatelet therapy can be lifesaving.

18 Mar 2019

Study confirms sensitivity of microbiological cultures for detecting cholera

Recently, the sensitivity of fecal microbiological cultures for detecting cholera has come under question. Researchers reporting in PLOS Neglected Tropical Diseases investigated this claim using a ‘vaccine probe’ analysis of a completed cholera vaccine cluster randomized trial to support the sensitivity of conventional microbiological culture for cholera.

15 Mar 2019

Shorter treatment for Chagas disease found to be effective and safer than standard treatment

A two-week treatment course for adult patients with chronic Chagas disease showed, when compared to placebo, similar efficacy and significantly fewer side effects than the standard treatment duration of eight weeks, according to the results of a clinical trial in Bolivia led by the Drugs for Neglected Diseases initiative.

14 Mar 2019

Success for new cholesterol-lowering drug

A new, oral drug that effectively lowers LDL or "bad" cholesterol, looks set for clinical approval.

14 Mar 2019

Study unravels how cancer medication works in brains of Parkinson's patients

Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson's disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms of Parkinson's, such as motor dysfunction, are a result of a dopamine loss.

13 Mar 2019

Fear center in the brain provides protection against body perception disorders

If functionality of the brain's amygdala is impaired, illusory perceptions arise much faster and more pronounced.

13 Mar 2019

Brain stimulation reduces depression symptoms, shows study

With a weak alternating electrical current sent through electrodes attached to the scalp, UNC School of Medicine researchers successfully targeted a naturally occurring electrical pattern in a specific part of the brain and markedly improved depression symptoms in about 70 percent of participants in a clinical study.

12 Mar 2019

Proving the efficacy of traditional Chinese medicine

Using GC-MS, scientists have uncovered the anti-pyretic mechanisms of Jinxin, a traditional Chinese medicine typically prescribed for fever.

11 Mar 2019

Diet reverses Alzheimer’s-like symptoms in mice

A diet containing compounds found in green tea and carrots reversed Alzheimer's-like symptoms in mice genetically programmed to develop the disease, USC researchers say.

7 Mar 2019

Fecal transplantation improves the gut of IBS patients

Transplantation of feces from a healthy person to a patient suffering of irritable bowel syndrome improved both symptoms of IBS and the gut's bacteria profile.

7 Mar 2019

Multivitamins do not help stave off depression but lifestyle coaching may work

A new study has contradicted the existing understanding that taking daily nutritional supplements may help to prevent depression.

6 Mar 2019

Patients experiment with prescription drugs to fight aging

Dr. Alan Green's patients travel from around the country to his tiny practice in Queens, N.Y., lured by the prospect of longer lives.

6 Mar 2019

Study examines effect of herbal medicine product on bedwetting in children

A new clinical trial investigating whether an herbal medicine product can benefit school-age children experiencing bedwetting is being led by a collaboration between researchers from the Australian Research Centre in Complementary and Integrative Medicine at the University of Technology Sydney and the Office of Research at Endeavour College of Natural Health.

5 Mar 2019

Daily consumption of nutritional supplements does not prevent depression

MooDFOOD, the largest randomized clinical trial to study the effects of nutritional strategies on the prevention of major depressive disorder concludes that daily intake of nutritional supplements cannot prevent depression.

5 Mar 2019

Study: Using steroids during cardic bypass surgery did not reduce acute kidney injury risk

Using steroids during cardiopulmonary bypass surgery did not reduce the risk of acute kidney injury in people at increased risk of death, according to a study conducted in 18 countries published in CMAJ.

4 Mar 2019